Clinical Trial

Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to investigate the possible efficacy of vonoprazan versus Pantoprazole in patients with gastroesophageal reflux disease.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-08-18; most recent amendment 2024-12-04.
Status change: Not Yet Recruiting → Recruiting 2024-10-09
Trial Details
NCT Number NCT06564246
Lead Sponsor Tanta University
Conditions Gastroesophageal Reflux Disease (GERD)
Enrollment 44 participants
Start Date 2024-09-18
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2024-12-05